The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.

The agency is inviting public comment on a new discussion paper as it prepares to shape policy covering robotic medical ...

Edwards’ TAVR device in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation ...

CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did ...

The CEO change was unexpected and prompted a stock selloff Friday, analysts said, but the new chief executive is prepared for ...

Patients, providers and medtech firms submitted hundreds of comments to the Food and Drug Administration on how the agency ...

Philips will pay 288 million euros to settle an investigation related to its recall of millions of sleep and respiratory ...

Like Impella, Vitalyst is a pump that provides temporary mechanical circulatory support. Vitalyst features a magnetically driven impeller, potentially lowering the risk of vascular complications, and ...